Fibrolamellar Liver Cancer
1 clinical trials · Condition
◉ Watch Fibrolamellar Liver Cancer
| Record | Firm | Date |
|---|---|---|
| Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) (NCT01642186) | Memorial Sloan Kettering Cancer Center | 2012-07-12 |
Track Fibrolamellar Liver Cancer automatically
Every clearance here is in the API, with alerts when new ones post.